Skip to main content

Phenobarbital News

Many Women With Epilepsy Unaware of Seizure Meds' Risks to Pregnancy

FRIDAY, Dec. 6, 2024 – Many women with epilepsy who are of childbearing age might not realize their anti-seizure drugs can raise the risk of birth defects or dampen the effectiveness of their birth...

FDA Approves Sezaby (phenobarbital sodium powder for injection) for the Treatment of Neonatal Seizures

First and only product approved for treating seizures in neonatal patients Mumbai, India, November 18, 2022 – Sun Pharmaceutical Industries Limited and Sun Pharma Advanced Research Company Ltd. t...

FDA Medwatch Alert: Phenobarbital 15 mg Tablets, USP by C.O. Truxton: Recall - Labeling Error on Declared Strength

ISSUE: C.O. Truxton, Inc. is voluntarily recalling lot 70952A of Phenobarbital Tablets, USP, 15 mg, to the consumer/user level. The manufacturer received a confirmed customer complaint that a bottle...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Epilepsy, Sedation, Seizures, Insomnia

Phenobarbital patient information at Drugs.com